ES
34
-2
ABBV
68
2
DO
47
-2
JBHT
49
6
HSY
50
2
CSX
50
2
ACN
42
2
PBI
43
5
R
63
2
AES
47
-8
MCD
54
-5
GOOGL
70
-2
WAT
38
2
URBN
50
-12
MET
58
-2
UNH
42
4
ADBE
70
2
NSC
48
3
SBUX
35
2
EMR
44
-7
ES
34
-2
ABBV
68
2
DO
47
-2
JBHT
49
6
HSY
50
2
CSX
50
2
ACN
42
2
PBI
43
5
R
63
2
AES
47
-8
MCD
54
-5
GOOGL
70
-2
WAT
38
2
URBN
50
-12
MET
58
-2
UNH
42
4
ADBE
70
2
NSC
48
3
SBUX
35
2
EMR
44
-7
Financhill
Back

Shinkin Central Bank Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
30

SKCBY
Shinkin Central Bank

Last Price:
8.37
Seasonality Move:
0%
Buy
52

SRPT
Sarepta Therapeutics

Last Price:
157.93
Seasonality Move:
18.65%
Sell
30
Shinkin Central Bank (SKCBY) is a Sell

Is Shinkin Central Bank a Buy, Sell or Hold?

  • The current Shinkin Central Bank [SKCBY] share price is $8.37. The Score for SKCBY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • SKCBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $157.74. The Score for SRPT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SKCBY Stock Price Chart

What is Shinkin Central Bank's stock price today?

  • The Shinkin Central Bank share price today is $8.37
    The current trend is relatively stagnant and SKCBY is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $157.74
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight selling pressure.

SKCBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Sell
Relative Strength Index (14 RSI): 0 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.37 - 8.37) Sell
Bollinger Bands (100): (8.37 - 8.37) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.67 Buy
Relative Strength Index (14 RSI): 68.69 Buy
Chaikin Money Flow: -86202 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (114.06 - 147.06) Buy
Bollinger Bands (100): (118.53 - 137.75) Buy

SKCBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.37 Sell
20-day SMA: 8.37 Sell
50-day SMA: 8.37 Sell
200-day SMA: 8.37 Sell
8-day EMA: 8.37 Sell
20-day EMA: 8.37 Sell
50-day EMA: 8.37 Sell
200-day EMA: 8.36 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 149.53 Buy
20-day SMA: 132.97 Buy
50-day SMA: 129.56 Buy
200-day SMA: 115.84 Buy
8-day EMA: 150.26 Buy
20-day EMA: 138.97 Buy
50-day EMA: 131.58 Buy
200-day EMA: 121.41 Buy

Shinkin Central Bank Earnings Growth & SKCBY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.

Shinkin Central Bank Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):